Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor 1 or MSHR or MC1R) - Pipeline Review, H2 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor 1 or MSHR or MC1R) - Pipeline Review, H2 2016" drug pipelines to their offering.

This report provides comprehensive information on the therapeutic development for Melanocyte Stimulating Hormone Receptor, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Melanocyte Stimulating Hormone Receptor and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Mentioned:

  • Clinuvel Pharmaceuticals Limited
  • Mallinckrodt Plc
  • Palatin Technologies, Inc.
  • Retrophin Inc.
  • SolaranRx, Inc

Key Topics Covered:

  • Introduction
  • Melanocyte Stimulating Hormone Receptor Overview
  • Therapeutics Development
  • Pipeline Products for Melanocyte Stimulating Hormone Receptor - Overview
  • Pipeline Products for Melanocyte Stimulating Hormone Receptor - Comparative Analysis
  • Melanocyte Stimulating Hormone Receptor - Therapeutics under Development by Companies
  • Melanocyte Stimulating Hormone Receptor - Therapeutics under Investigation by Universities/Institutes
  • Melanocyte Stimulating Hormone Receptor - Pipeline Products Glance
  • Late Stage Products
  • Clinical Stage Products
  • Early Stage Products
  • Melanocyte Stimulating Hormone Receptor - Products under Development by Companies
  • Melanocyte Stimulating Hormone Receptor - Products under Investigation by Universities/Institutes
  • Melanocyte Stimulating Hormone Receptor - Companies Involved in Therapeutics Development

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/qgwjq4/melanocyte

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Endocrine and Metabolic Disorder Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Endocrine and Metabolic Disorder Drugs